Molecular characterization and antiviral analyses of porcine type III interferons

Journal of Interferon and Cytokine Research

Volumn 30, Issue 11, 2010, Pages 801-807

  Sang, Yongming ^a   Rowland, Raymond R R ^b   Blecha, Frank ^a  

^a Analytical and Toxicological Services   (United States)

^b KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTIVIRUS AGENT; CYTOKINE; DELTA INTERFERON 1; DELTA INTERFERON 3; INTERFERON; MESSENGER RNA; UNCLASSIFIED DRUG;

ADENOVIRUS; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTERIVIRUS; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; EPITHELIUM CELL; HOST PATHOGEN INTERACTION; INTESTINE; LIVER; MESENTERY LYMPH NODE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PARALOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SWINE;

AMINO ACID SEQUENCE; ANIMALS; CLONING, MOLECULAR; HUMANS; INTERFERONS; INTESTINES; KIDNEY; MOLECULAR SEQUENCE DATA; ORGAN SPECIFICITY; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; RNA, DOUBLE-STRANDED; SWINE;

ADENOVIRIDAE; ARTERIVIRUS; SUIDAE; SUS; SUS SCROFA;

EID: 78149326830     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2010.0016     Document Type: Article

References (30)

1. Ank N, Iversen MB, Bartholdy C, Staeheli P, Hartmann R, Jensen UB, Dagnaes-Hansen F, Thomsen AR, Chen Z, Haugen H, Klucher K, Paludan SR. 2008. An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity. J Immunol 180:2474-2485.
2. Ank N, Paludan SR. 2009. Type III IFNs: new layers of complexity in innate antiviral immunity. Biofactors 35:82-87.
3. Ank N, West H, Paludan SR. 2006. IFN-lambda: novel antiviral cytokines. J Interferon Cytokine Res 26:373-379.
4. Borden EC, Sen GC, Uze G, Silverman RH, Ransohoff RM, Foster GR, Stark GR. 2007. Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov 6:975-990.
5. Dumoutier L, Tounsi A, Michiels T, Sommereyns C, Kotenko SV, Renauld JC. 2004. Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling. J Biol Chem 279:32269-32274.
6. Fox BA, Sheppard PO, O'Hara PJ. 2009. The role of genomic data in the discovery, annotation and evolutionary interpretation of the interferon-lambda family. PLoS ONE 4:e4933.
7. Gad HH, Dellgren C, Hamming OJ, Vends S, Paludan SR, Hartmann R. 2009. Interferon-lambda is functionally an interferon but structurally related to the interleukin-10 family. J Biol Chem 284:20869-20875.
8. Hagedorn TM, Carlin RW, Schultz BD. 2007. Oxytocin and vasopressin stimulate anion secretion by human and porcine vas deferens epithelia. Biol Reprod 77:416-424.
9. Hall TA. 1999. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/ NT. Nucleic Acids Symp Ser 41:95-98.
10. Kolodziej PA, Young RA. 1991. Epitope tagging and protein surveillance. Methods Enzymol 194:508-519.
11. Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK, Langer JA, Sheikh F, Dickensheets H, Donnelly RP. 2003. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 4:69-77.
12. Kozak M. 1987. An analysis of 50-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res 15:8125-8148.
13. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, Thompson JD, Gibson TJ, Higgins DG. 2007. ClustalW and ClustalX version 2. Bioinformatics 23:2947-2948.
14. Mahdi RN, Rouchka EC. 2009. RBF-TSS: identification of transcription start site in human using radial basis functions network and oligonucleotide positional frequencies. PLoS ONE 4:e4878.
15. Meager A, Visvalingam K, Dilger P, Bryan D, Wadhwa M. 2005. Biological activity of interleukins-28 and -29: comparison with type I interferons. Cytokine 31:109-118.
16. Ohler U, Niemann H. 2001. Identification and analysis of eukaryotic promoters: recent computational approaches. Trends Genet 17:56-60.
17. Onoguchi K, Yoneyama M, Takemura A, Akira S, Taniguchi T, Namiki H, Fujita T. 2007. Viral infections activate types I and III interferon genes through a common mechanism. J Biol Chem 282:7576-7581.
18. Osterlund PI, Pietilä TE, Veckman V, Kotenko SV, Julkunen I. 2007. IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes. J Immunol 179:3434-3442.
19. Pestka S. 2007. The interferons: 50 years after their discovery, there is much more to learn. J Biol Chem 282:20047-20051.
20. Rost B, Yachdav G, Liu J. 2004. The PredictProtein server. Nucleic Acids Res 32(Web Server issue):W321-W326.
21. Sang Y, Patil AA, Zhang G, Ross CR, Blecha F. 2006. Bioinformatic and expression analysis of novel porcine b-defensins. Mamm Genome 17:332-339.
22. Sang Y, Ramanathan B, Ross CR, Blecha F. 2005. Gene silencing and overexpression of porcine peptidoglycan recognition protein long isoforms: involvement in beta-defensin-1 expression. Infect Immun 73:7133-7141.
23. Sang Y, Ross CR, Rowland RR, Blecha F. 2008. Toll-like receptor 3 activation decreases porcine arterivirus infection. Viral Immunol 21:303-313.
24. Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE, Kuestner R, Garrigues U, Birks C, Roraback J, Ostrander C, Dong D, Shin J, Presnell S, Fox B, Haldeman B, Cooper E, Taft D, Gilbert T, Grant FJ, Tackett M, Krivan W, McKnight G, Clegg C, Foster D, Klucher KM. 2003. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 4:63-68.
25. Sommereyns C, Paul S, Staeheli P, Michiels T. 2008. IFN-lambda is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog 4:e1000017.
26. Takeuchi O, Akira S. 2009. Innate immunity to virus infection. Immunol Rev 227:75-86.
27. Wang J, Oberley-Deegan R, Wang S, Nikrad M, Funk CJ, Hartshorn KL, Mason RJ. 2009. Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-lambda1) in response to influenza A infection. J Immunol 182:1296-1304.
28. Yeh RF, Lim LP, Burge CB. 2001. Computational inference of homologous gene structures in the human genome. Genome Res 11:803-816.
29. Zhang SY, Boisson-Dupuis S, Chapgier A, Yang K, Bustamante J, Puel A, Picard C, Abel L, Jouanguy E, Casanova JL. 2008. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense. Immunol Rev 226:29-40.
30. Zhou L, Wang X, Wang YJ, Zhou Y, Hu S, Ye L, Hou W, Li H, Ho WZ. 2009. Activation of toll-like receptor-3 induces interferon-lambda expression in human neuronal cells. Neuroscience 159:629-637.